These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 311530)

  • 1. Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays.
    Brinkhous KM; Read MS
    Thromb Res; 1978 Oct; 13(4):591-7. PubMed ID: 311530
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor.
    Brinkhous KM; Read MS
    Blood; 1980 Mar; 55(3):517-20. PubMed ID: 6965594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.
    Read MS; Shermer RW; Brinkhous KM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4514-8. PubMed ID: 309134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Feb 1-15; 17(3-4):443-52. PubMed ID: 6966083
    [No Abstract]   [Full Text] [Related]  

  • 6. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
    Hashimoto S; Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
    [No Abstract]   [Full Text] [Related]  

  • 7. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets.
    Finlay TH; Marcus DL; Kowalski S; Silber P
    Biochim Biophys Acta; 1981 Jan; 672(1):79-88. PubMed ID: 6260227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of platelet aggregating factor/vom Willebrand factor in various species.
    Brinkhous KM; Thomas BD; Ibrahim SA; Read MS
    Thromb Res; 1977 Sep; 11(3):345-55. PubMed ID: 411191
    [No Abstract]   [Full Text] [Related]  

  • 13. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
    Coller BS
    J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ristocetin and von Willebrand factor.
    Jenkins CS; Meyer D; Larrieu MJ
    Thromb Haemost; 1976 Jun; 35(3):752-3. PubMed ID: 1086517
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Purification of ristocetin Willebrand factor (RWF).
    Olson JD; Fass DN; Brockway WJ; Bowie EJ; Mann KG
    Thromb Diath Haemorrh; 1975 Nov; 34(2):606. PubMed ID: 1081753
    [No Abstract]   [Full Text] [Related]  

  • 20. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.